Transient B Cell Depletion or Improved Transgene Expression by Codon Optimization Promote Tolerance to Factor VIII in Gene Therapy

The major complication in the treatment of hemophilia A is the development of neutralizing antibodies (inhibitors) against factor VIII (FVIII). The current method for eradicating inhibitors, termed immune tolerance induction (ITI), is costly and protracted. Clinical protocols that prevent rather tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Sack, Brandon K., Merchant, Sherin, Markusic, David M., Nathwani, Amit C., Davidoff, Andrew M., Byrne, Barry J., Herzog, Roland W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359994/
https://www.ncbi.nlm.nih.gov/pubmed/22655063
http://dx.doi.org/10.1371/journal.pone.0037671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359994/
https://www.ncbi.nlm.nih.gov/pubmed/22655063
http://dx.doi.org/10.1371/journal.pone.0037671

Ejemplares similares